ASCLETIS-B (01672) spent HKD 2.5386 million to repurchase 200,000 shares on December 18th.
Song Li Pharmaceutical -B (01672) announced that it will repurchase 200,000 shares at a cost of 2.5386 million Hong Kong dollars on December 18, 2025.
Ascletis-B (01672) announced that it will repurchase 200,000 shares for 2.5386 million Hong Kong dollars on December 18, 2025.
Related Articles
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
